Lu Wang

4.7k total citations · 2 hit papers
141 papers, 3.0k citations indexed

About

Lu Wang is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Lu Wang has authored 141 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Molecular Biology, 32 papers in Cancer Research and 27 papers in Immunology. Recurrent topics in Lu Wang's work include Inflammasome and immune disorders (19 papers), MicroRNA in disease regulation (14 papers) and Cancer Immunotherapy and Biomarkers (9 papers). Lu Wang is often cited by papers focused on Inflammasome and immune disorders (19 papers), MicroRNA in disease regulation (14 papers) and Cancer Immunotherapy and Biomarkers (9 papers). Lu Wang collaborates with scholars based in China, United States and Netherlands. Lu Wang's co-authors include Hao Zhang, Hui‐Chuan Sun, Wei‐Zhong Wu, Zhao–You Tang, Xiao Xiong, Ling–Qun Kong, Peng–Yuan Zhuang, Huaxiang Xu, Xiao‐Dong Zhu and Yuquan Xiong and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Lu Wang

131 papers receiving 3.0k citations

Hit Papers

A signature of saliva-derived exosomal small RNAs as pred... 2022 2026 2023 2024 2022 2024 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lu Wang China 30 1.6k 683 615 543 348 141 3.0k
Jing Hu China 32 1.9k 1.2× 825 1.2× 627 1.0× 429 0.8× 377 1.1× 175 3.9k
Qian Sun China 31 1.5k 0.9× 622 0.9× 768 1.2× 752 1.4× 231 0.7× 106 3.8k
Jianfeng Li China 34 1.7k 1.1× 680 1.0× 961 1.6× 550 1.0× 381 1.1× 162 4.7k
Hongyan Wang China 32 1.9k 1.2× 830 1.2× 457 0.7× 518 1.0× 460 1.3× 191 3.7k
Liantao Li China 27 1.2k 0.7× 368 0.5× 869 1.4× 567 1.0× 280 0.8× 115 2.9k
Li Xu China 32 1.6k 1.0× 646 0.9× 401 0.7× 327 0.6× 262 0.8× 155 3.4k
Ning Liu China 31 1.3k 0.8× 494 0.7× 413 0.7× 295 0.5× 220 0.6× 189 3.0k
Min Hu China 27 1.2k 0.7× 651 1.0× 629 1.0× 424 0.8× 238 0.7× 144 2.8k
Shanshan Wang China 34 1.8k 1.1× 543 0.8× 465 0.8× 870 1.6× 394 1.1× 182 3.9k
Lu Wang China 32 1.4k 0.9× 672 1.0× 783 1.3× 553 1.0× 448 1.3× 122 3.5k

Countries citing papers authored by Lu Wang

Since Specialization
Citations

This map shows the geographic impact of Lu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Wang more than expected).

Fields of papers citing papers by Lu Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Wang. The network helps show where Lu Wang may publish in the future.

Co-authorship network of co-authors of Lu Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Lu Wang. A scholar is included among the top collaborators of Lu Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu Wang. Lu Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wang, Lu, et al.. (2024). Puerarin reduces diabetic nephropathy-induced podocyte pyroptosis by modulating the SIRT1/NLRP3/caspase-1 pathway. Molecular and Cellular Endocrinology. 595. 112409–112409. 4 indexed citations
4.
Wang, Lu, Huijuan Liu, Yiqian Liu, et al.. (2024). miR-451a was selectively sorted into exosomes and promoted the progression of esophageal squamous cell carcinoma through CAB39. Cancer Gene Therapy. 31(7). 1060–1069. 2 indexed citations
5.
Wang, Lu, et al.. (2024). Resource Allocation for ISAC Networks with Application to Target Tracking. 1–6. 1 indexed citations
6.
Song, Wenyu, Hongye Wang, Lu Wang, et al.. (2023). Decoding the metastatic potential and optimal postoperative adjuvant therapy of melanoma based on metastasis score. Cell Death Discovery. 9(1). 397–397. 7 indexed citations
7.
Li, Kai, Yusheng Lin, Yu Zhou, et al.. (2023). Salivary Extracellular MicroRNAs for Early Detection and Prognostication of Esophageal Cancer: A Clinical Study. Gastroenterology. 165(4). 932–945.e9. 40 indexed citations
8.
Wang, Lu, Jinghua Pan, Zhimeng Yao, et al.. (2022). Targeting PELP1 Attenuates Angiogenesis and Enhances Chemotherapy Efficiency in Colorectal Cancer. Cancers. 14(2). 383–383. 6 indexed citations
9.
Meng, Fanchao, Haimin Chen, Lu Wang, et al.. (2022). Bibliometric and visualization analysis of literature relating to diabetic erectile dysfunction. Frontiers in Endocrinology. 13. 1091999–1091999. 4 indexed citations
10.
Wei, Junjie, Shaojuan Zhang, Chenchen Dong, et al.. (2022). Easily automated radiosynthesis of [18F]P10A-1910 and its clinical translation to quantify phosphodiesterase 10A in human brain. Frontiers in Bioengineering and Biotechnology. 10. 983488–983488. 1 indexed citations
11.
Wang, Shuhong, Yusheng Lin, Xiao Xiong, et al.. (2020). Low-Dose Metformin Reprograms the Tumor Immune Microenvironment in Human Esophageal Cancer: Results of a Phase II Clinical Trial. Clinical Cancer Research. 26(18). 4921–4932. 119 indexed citations
12.
Wang, Lu, Tao Wu, Jun Xi, et al.. (2016). NLRP3 Activation Was Regulated by DNA Methylation Modification duringMycobacterium tuberculosisInfection. BioMed Research International. 2016. 1–10. 56 indexed citations
13.
Yao, Hui, Linbo Chen, Xiongbin Chen, et al.. (2016). Anti-aging effects of angelica sinensis polysaccharides on brain aging induced by D-galactose in Nestin-green fluorescent protein transgenic mice and its mechanism. 47(6). 731–737. 2 indexed citations
14.
Wang, Lu, Shengpeng Wang, Ruie Chen, et al.. (2014). Oridonin Loaded Solid Lipid Nanoparticles Enhanced Antitumor Activity in MCF‐7 Cells. Journal of Nanomaterials. 2014(1). 18 indexed citations
15.
Wang, Lu, et al.. (2013). Prevalence of coal workers’ pneumoconiosis in China: A systematic analysis of 2001–2011 studies. International Journal of Hygiene and Environmental Health. 217(1). 46–51. 84 indexed citations
16.
Zhao, Yiming, Hongwei He, Xilong Wang, et al.. (2011). HIWI is associated with prognosis in patients with hepatocellular carcinoma after curative resection. Cancer. 118(10). 2708–2717. 79 indexed citations
17.
Wang, Lu, et al.. (2011). Construction of RNAi Vector of NtLS Gene and its Transformation in Tobacco. 1 indexed citations
18.
Zhang, Wei, Xiao‐Dong Zhu, Hui‐Chuan Sun, et al.. (2010). Depletion of Tumor-Associated Macrophages Enhances the Effect of Sorafenib in Metastatic Liver Cancer Models by Antimetastatic and Antiangiogenic Effects. Clinical Cancer Research. 16(13). 3420–3430. 330 indexed citations
19.
Wang, Lu, et al.. (2008). NtGNL1 is involved in embryonic cell division patterning, root elongation, and pollen tube growth in tobacco. New Phytologist. 179(1). 81–93. 13 indexed citations
20.
Wang, Jian, Qiong Xue, Weidong Jia, et al.. (2003). Octreotide acts as an antitumor angiogenesis compound and suppresses tumor growth in nude mice bearing human hepatocellular carcinoma xenografts. Journal of Cancer Research and Clinical Oncology. 129(6). 327–334. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026